This inventor holds 1 USPTO granted patent. Top assignees: Nec Corporation, University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 36,735 
1 out of 9 Years Active: 2026
Title: Naoki Imaizumi: Advancing Diagnosis of HTLV-1-Related Disease.
Introduction
Naoki Imaizumi is an inventor associated with Okinawa, Japan. His work includes a diagnostic method designed to help identify human T-cell leukemia virus type 1 (HTLV-1)-related disease using a blood sample.
Latest Patents
Imaizumi is associated with 1 patent, titled “Method for Diagnosing Human T-Cell Leukemia Virus Type 1 (HTLV-1)-Related Disease.” The method assesses the amount of tumor necrosis factor receptor 2 (TNFR2) in a subject’s blood. An increase in TNFR2 may indicate that the subject has, or is likely to develop, an HTLV-1-related disease. A decrease may indicate that the disease is in remission or is likely to enter remission. The approach aims to support simple and accurate diagnosis and monitoring.
Career Highlights
The provided career information associates Imaizumi with NEC Corporation and a university. These affiliations place his work in both corporate and academic settings.
Collaborations
His listed coworkers include Yoshiko Yoshihara and Takuya Fukushima. Their names are associated with his professional and inventive work.
Conclusion
Naoki Imaizumi’s patent focuses on using TNFR2 levels in blood to support the diagnosis and assessment of HTLV-1-related disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile